Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 22;11(1):e001314.
doi: 10.1136/bmjgast-2023-001314.

Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial)

Collaborators, Affiliations

Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial)

Dhiraj Tripathi et al. BMJ Open Gastroenterol. .

Abstract

Introduction: In liver cirrhosis, acute variceal bleeding (AVB) is associated with a 1-year mortality rate of up to 40%. Data on early or pre-emptive transjugular intrahepatic portosystemic stent-shunt (TIPSS) in AVB is inconclusive and may not reflect current management strategies. Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in AVB (REACT-AVB) aims to investigate the clinical and cost-effectiveness of early TIPSS in patients with cirrhosis and AVB after initial bleeding control.

Methods and analysis: REACT-AVB is a multicentre, randomised controlled, open-label, superiority, two-arm, parallel-group trial with an internal pilot. The two interventions allocated randomly 1:1 are early TIPSS within 4 days of diagnostic endoscopy or secondary prophylaxis with endoscopic therapy in combination with non-selective beta blockers. Patients aged ≥18 years with cirrhosis and Child-Pugh Score 7-13 presenting with AVB with endoscopic haemostasis are eligible for inclusion. The primary outcome is transplant-free survival at 1 year post randomisation. Secondary endpoints include transplant-free survival at 6 weeks, rebleeding, serious adverse events, other complications of cirrhosis, Child-Pugh and Model For End-Stage Liver Disease (MELD) scores at 6 and 12 months, health-related quality of life, use of healthcare resources, cost-effectiveness and use of cross-over therapies. The sample size is 294 patients over a 4-year recruitment period, across 30 hospitals in the UK.

Ethics and dissemination: Research ethics committee of National Health Service has approved REACT-AVB (reference number: 23/WM/0085). The results will be submitted for publication in a peer-reviewed journal. A lay summary will also be emailed or posted to participants before publication.

Trial registration number: ISRCTN85274829; protocol version 3.0, 1 July 2023.

Keywords: CIRRHOSIS; GASTROINTESTINAL BLEEDING; OESOPHAGEAL VARICES; PORTAL HYPERTENSION; STENTS.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Trial schema.
Figure 2
Figure 2
Details of health technologies. NSBB, non-selective beta blocker; TIPSS, transjugular intrahepatic portosystemic stent–shunt.

Similar articles

Cited by

References

    1. NICE . Cirrhosis in over 16S: assessment and management. London: NICE, 2016. - PubMed
    1. Jairath V, Rehal S, Logan R, et al. . Acute Variceal haemorrhage in the United kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis 2014;46:419–26. 10.1016/j.dld.2013.12.010 - DOI - PubMed
    1. Tripathi D, Stanley AJ, Hayes PC, et al. . Guidelines on the management of Variceal haemorrhage in Cirrhotic patients. Gut 2015;64:1680–704. 10.1136/gutjnl-2015-309262 - DOI - PMC - PubMed
    1. de Franchis R, Bosch J, Garcia-Tsao G, et al. . Renewing consensus in portal hypertension. J Hepatol 2022;76:959–74. 10.1016/j.jhep.2021.12.022 - DOI - PMC - PubMed
    1. Maimone S, Saffioti F, Filomia R, et al. . Predictors of re-bleeding and mortality among patients with refractory Variceal bleeding undergoing salvage Transjugular Intrahepatic Portosystemic shunt (TIPS). Dig Dis Sci 2019;64:1335–45. 10.1007/s10620-018-5412-x - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources